The first ‘real-world study’ into the weight loss drug, Mounjaro, has now started in Greater Manchester. Thousands of Mancunians are anticipated to test the GLP-1 drug to see if it could help people ...
Officers raided an address in the Llanrwst area following reports that prescription weight-loss drugs were being sold without ...
Novo Nordisk finds itself navigating significant operational and market headwinds. The company is intensely focused on maintaining its leadership in the obes ...
One of the reasons for the internal disagreement at the club was the fact that the nutritionist Eduardo Rauen, who has been ...
If you miss a dose of your weight loss or type 2 diabetes GLP-1 medication, you may not feel any differently right away, says Cecilia Low Wang, MD, a professor of medicine and director of the Glucose ...
From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...
Congress has the power to make obesity treatment and weight management accessible to the communities that need it.
A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...
Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...
The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback